PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B

International Journal of Pharmaceutics

Volumn 387, Issue 1-2, 2010, Pages 253-262

  Jain, Arvind K ^a   Goyal, Amit K ^a,b   Mishra, Neeraj ^a   Vaidya, Bhuvaneshwar ^a   Mangal, Sharad ^a   Vyas, Suresh P ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b ISF COLLEGE OF PHARMACY   (India)

Author keywords

Nanoparticles; Oral vaccine; PLA; PLA PEG; Triblock copolymer

Indexed keywords

COPOLYMER; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; INTERLEUKIN 2; INTERLEUKIN 4; MACROGOL; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; FLUORESCENCE MICROSCOPY; HEPATITIS B; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; STOMACH JUICE; ZETA POTENTIAL;

ADMINISTRATION, ORAL; ANIMALS; DRUG STABILITY; FEMALE; GASTRIC JUICE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; INTESTINAL MUCOSA; INTESTINAL SECRETIONS; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS;

EID: 77649180085     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.12.013     Document Type: Article

References (36)

1. Anderson J.M., Shive M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliver. Rev. 1997, 28:5-24.
2. Audran R., Men Y., Johanson P., Gander B., Corradin G. Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agent. Pharm. Res. 1998, 15:1111-1116.
3. Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007, 25:5467-5484.
4. Brooking J., Davis S.S., Illum L. Transport of nanoparticles across the rat nasal mucosa. J. Drug Target. 2001, 9:267-279.
5. Burkersoda F.V., Gref R., Gopferich A. Erosion of biodegradable block copolymers made of poly(d,l-lactic acid) and poly(ethylene glycol). Biomaterials 1997, 18:1599-1607.
6. Debin A., Kravtzoff R., Santiago J.V., Cazales L., Sperandio S., Melber K., Janowicz Z., Betbeder D., Moynier M. Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses. Vaccine 2002, 20:2752-2763.
7. Delgado A., Lavelle E.C., Hartshorne M., Davis S.S. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems. Vaccine 1999, 17:2927-2938.
8. Elson C.O., Ealding W., Lefkowitz J. A lavage technique following repeated measurement of IgA antibody in mouse intestinal secretions. J. Immunol. Methods 1984, 67:101-108.
9. Fasano A. Modulation of intestinal permeability: an innovative method of oral drug delivery for the treatment of inherited and acquired human diseases. Mol. Genet. Metab. 1998, 64:12-18.
10. Garinot M., Fiévez V., Pourcelle V., Stoffelbach F., des Rieux A., Plapied L., Theate I., Freichels H., Jérôme C., Marchand-Brynaert J., Schneider Y.J., Préat V. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J. Control. Release 2007, 120:195-204.
11. Goyal A.K., Khatri K., Mishra N., Mehta A., Vaidya B., Tiwari S., Vyas S.P. Aquasomes-a nanoparticulate approach for the delivery of antigen. Drug Dev. Ind. Pharm. 2008, 34:1297-1305.
12. Gupta P.N., Khatri K., Goyal A.K., Mishra N., Vyas S.P. M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. J. Drug Target. 2007, 15:701-713.
13. Hu Y., Xie J., Tong Y.W., Wang C.H. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. J. Control. Release 2007, 118:7-17.
14. Jaganathan K.S., Vyas S.P. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant Hepatitis B antigen administered intranasally. Vaccine 2006, 24:4201-4211.
15. Jaganathan K.S., Vyas S.P. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine 2006, 24:4201-4211.
16. Jain A.K., Goyal A.K., Gupta P.N., Khatri K., Mishra N., Mehta A., Mangal S., Vyas S.P. Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B. J. Control. Release 2009, 136:161-169.
17. Jain S., Singh P., Mishra V., Vyas S.P. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol. Lett. 2005, 101:41-49.
18. Jani P., Halbert G.W., Langridge J., Florence A.T. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 1990, 42:821-826.
19. Jeong B., Bae Y.H., Lee D.S., Kim S.W. Biodegradable block copolymers as injectable drug-delivery systems. Nature 1997, 388:860-862.
20. Johanson P., Men Y., Audran R., Corradin G., Merkel H.P., Gander B. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives. Pharm. Res. 1998, 15:1103-1110.
21. Jung T., Kamm W., Breitenbach A., Kaiserling E., Xiao J.X., Kissel T. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?. Eur. J. Pharm. Biopharm. 2000, 50:147-160.
22. Khatri K., Goyal A.K., Gupta P.N., Mishra N., Mehta A., Vyas S.P. Surface modified liposomes for nasal delivery of DNA vaccine. Vaccine 2008, 26:2225-2233.
23. Kim B., Bowersock T., Griebel P., Kidane A., Babiuk L.A., Sanchez M., Attah-Poku S., Kaushik R.S., Mutwiri G.K. Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres. J. Control. Release 2002, 85:191-202.
24. Morishita M., Peppas N.A. Is the oral route possible for peptide and protein drug delivery?. Drug Discov. Today 2006, 11:905-910.
25. O'Hagan D.T., Palin K.J., Davis S.S. Intestinal absorption of proteins and macromolecules and the immunological response. Crit. Rev. Ther. Drug Carrier Sys. 1987, 4:197-220.
26. Page D.T., Cudmore S. Innovations in oral gene delivery: challenges and potentials. Drug Discov. Today 2001, 6:92-101.
27. Pitt C.G., Gratzl M.M., Kimmel G.L., Surles J., Schindler A. Aliphatic polyesters. II. The degradation of poly(dl-lactide), poly(e-caprolactone), and their copolymers in vivo. Biomaterials 1981, 2:215-220.
28. Prego C., García M., Torres D., Alonso M.J. Transmucosal macromolecular drug delivery. J. Control. Release. 2005, 101:151-162.
29. Prego C., Torres D., Fernandez-Megia E., Novoa-Carballal R., Quiñoá E., Alonso M.J. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree. J. Control. Release 2006, 111:299-308.
30. Rajkannan R., Dhanaraju M.D., Gopinath D., Selvaraj D., Jayakumar R. Development of hepatitis B oral vaccine using B-cell epitope loaded PLG microparticles. Vaccine 2006, 24:5149-5157.
31. Sachdeva S., Ahmad G., Malhotra P., Mukherjee P., Chauhan V.S. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 119 and 42kDa fragments expressed in Escherichia coli. Infect. Immun. 2004, 70:5775-5785.
32. Sharif S., O'Hagan D.T. A comparison of alternative methods for the determination of the levels of proteins entrapped in poly(lactide-co-glycolide) microparticles. Int. J. Pharm. 1995, 115:259-263.
33. Tobío M., Sánchez A., Vila A., Soriano I., Evora C., Vila-Jato J.L., Alonso M.J. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Colloids Surf. B 2000, 18:315-323.
34. Vila A., Gill H., McCallion O., Alonso M.J. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J. Control. Release 2004, 98:231-244.
35. Vila A., Sánchez A., Tobío M., Calvo P., Alonso M.J. Design of biodegradable particles for protein delivery. J. Control. Release 2002, 78:15-24.
36. Vyas S.P., Gupta P.N. Implication of nanoparticles/microparticles in mucosal vaccine delivery. Expert. Rev. Vaccines 2007, 6:401-418.